LOS ANGELES, Sept. 13 (Xinhua) -- The United States has authorized Omicron-specific vaccines last month, but for those familiar with the business tactics of the pharmaceutical industry, the messaging has caused considerable heartburn and raised an array of unanswered concerns, said a report of Kaiser Health News.
The updated shots easily clear the "safe and effective" bar for government authorization, said the report published on Monday.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
